Reagents that regulate human hematopoietin receptor-like protein and reagents which bind to human hematopoietin receptor-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, CNS disorders, COPD, cardiovascular disorders, liver disorders, cancer, asthma, and hematological disorders.

 
Web www.patentalert.com

< Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor

< Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration

> Novel compounds

> Novel compounds

~ 00221